Genmab — Juli 2020

[GeorgeBest]

[E_L]

Well done Helge, congratulations

[E_L]

Seattle Genetics, Inc. (SGEN) CEO Clay Siegall on Q2 2020 Results - Earnings Call Transcript - on TV - https://seekingalpha.com/article/4362785-seattle-genetics-inc-sgen-ceo-clay-siegall-on-q2-2020-results-earnings-call-transcript?part=single

[Mcjean]

Tillykke godt gået, hvornår kan vi forvente IPO til en favorabel pris til de trofaste inden børsnoteringen?

[E_L]

[E_L]

MS $HZNP: Raising PT on higher Tepezza; Reiterate OW rating: Risinger is significantly boosting our Tepezza sales estimates, which drives our earnings and PT higher. He is raising our PT from $50 to $70, supported by new valuation methodology.

[E_L]

AbbVie- why the CD3xCD20 would be best in class - efficacy data reported puts it at higher end, safety profile has been very favourable , SC formulation, dosing schedule fits very well in the diseases we are looking at- that makes it a very strong profile

[Tommy_P.]

Tillykke Helge!!

[lom]

Genmab Announces European Myeloma Network and Janssen Achieve Positive Topline Results from Phase 3 APOLLO Study of Daratumumab in Combination with Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

[deleted-user]

Det ser godt ud. Jeg må lige dykke ned i morgen.

[Jedi]

Even it was expected, nice to get confirmation of the Apollo study. I see no data in the announcement, but it should form basis for approval of Dara-Pom-dex as 3rd line therapy in Europe and ROW + confirmation of the FDA approval based on the EQUULEUS phase I study